0001140361-13-046219.txt : 20131213
0001140361-13-046219.hdr.sgml : 20131213
20131213194248
ACCESSION NUMBER: 0001140361-13-046219
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131211
FILED AS OF DATE: 20131213
DATE AS OF CHANGE: 20131213
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MYLAN INC.
CENTRAL INDEX KEY: 0000069499
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 251211621
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1500 CORPORATE DRIVE
CITY: CANONSBURG
STATE: PA
ZIP: 15317
BUSINESS PHONE: 724-514-1800
MAIL ADDRESS:
STREET 1: 1500 CORPORATE DRIVE
CITY: CANONSBURG
STATE: PA
ZIP: 15317
FORMER COMPANY:
FORMER CONFORMED NAME: MYLAN LABORATORIES INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: FRM CORP
DATE OF NAME CHANGE: 19711003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VANDERVEEN RANDALL L
CENTRAL INDEX KEY: 0001197539
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09114
FILM NUMBER: 131277487
MAIL ADDRESS:
STREET 1: 180 SPRINGMEADOW DRIVE
CITY: UPPER ST. CLAIR
STATE: PA
ZIP: 15244
4
1
doc1.xml
FORM 4
X0306
4
2013-12-11
0
0000069499
MYLAN INC.
MYL
0001197539
VANDERVEEN RANDALL L
1500 CORPORATE DRIVE
CANONSBURG
PA
15317
1
0
0
0
Common Stock
2013-12-11
4
M
0
2052
14.82
A
29488
D
Common Stock
2013-12-11
4
S
0
2052
42.281
D
27436
D
Common Stock
2013-12-12
4
M
0
7948
14.82
A
35384
D
Common Stock
2013-12-12
4
S
0
7948
42.00
D
27436
D
Stock Option Right to Buy
14.82
2013-12-11
4
M
0
2052
0
D
2004-07-30
2014-07-30
Common Stock
2052
7948
D
Stock Option Right to Buy
14.82
2013-12-12
4
M
0
7948
0
D
2004-07-30
2014-07-30
Common Stock
7948
0
D
Represents the weighted average price of the reporting person's disposition of 2,052 shares in transactions ranging from $42.00 to $42.45.
The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4.
This option exercise and the related sale of the underlying common stock were executed pursuant to a 10b5-1 trading plan dated November 25, 2013.
/s/ Randall L. Vanderveen
2013-12-13